VEGF in hepatocellular carcinoma and surrounding cirrhotic liver tissues.
作者信息
Mathonnet Muriel, Descottes Bernard, Valleix Denis, Labrousse François, Denizot Yves
出版信息
World J Gastroenterol. 2006 Feb 7;12(5):830-1. doi: 10.3748/wjg.v12.i5.830.
Abstract
摘要
相似文献
1
VEGF in hepatocellular carcinoma and surrounding cirrhotic liver tissues.
World J Gastroenterol. 2006 Feb 7;12(5):830-1. doi: 10.3748/wjg.v12.i5.830.
2
Immunohistochemical assessment of angiogenesis in hepatocellular carcinoma and surrounding cirrhotic liver tissues.
World J Gastroenterol. 2005 Feb 21;11(7):960-3. doi: 10.3748/wjg.v11.i7.960.
3
Increased expression of vascular endothelial growth factor in small hepatocellular carcinoma.
J Viral Hepat. 2007 Feb;14(2):133-9. doi: 10.1111/j.1365-2893.2006.00782.x.
4
Differential role of circulating endothelial progenitor cells in cirrhotic patients with or without hepatocellular carcinoma.
Dig Liver Dis. 2009 Dec;41(12):902-6. doi: 10.1016/j.dld.2009.04.013. Epub 2009 Jun 4.
5
[Expression of PTEN, Cx43, and VEGF in hepatocellular carcinoma].
Ai Zheng. 2004 Jun;23(6):662-6.
6
Different expression of VEGF and EGFL7 in human hepatocellular carcinoma.
Dig Liver Dis. 2016 Jan;48(1):76-80. doi: 10.1016/j.dld.2015.09.019. Epub 2015 Oct 9.
7
HGF, MET, and matrix-related proteases in hepatocellular carcinoma, fibrolamellar variant, cirrhotic and normal liver.
Mod Pathol. 2003 Jan;16(1):14-21. doi: 10.1097/01.MP.0000043521.96995.DB.
8
Levels of angiogenic proteins in plasma and platelets are not different between patients with hepatitis B/C-related cirrhosis and patients with cirrhosis and hepatocellular carcinoma.
Platelets. 2015;26(6):577-82. doi: 10.3109/09537104.2014.961415. Epub 2014 Oct 2.
9
Clinical significance of microvessel density and vascular endothelial growth factor expression in hepatocellular carcinoma and surrounding liver: possible involvement of vascular endothelial growth factor in the angiogenesis of cirrhotic liver.
Hepatology. 1998 Jun;27(6):1554-62. doi: 10.1002/hep.510270613.
10
Ganglioside variations in human liver cirrhosis and hepatocellular carcinoma as shown by two-dimensional thin-layer chromatography.
Clin Biochem. 1988 Dec;21(6):333-9. doi: 10.1016/s0009-9120(88)80013-4.
引用本文的文献
1
Critical signaling pathways governing hepatocellular carcinoma behavior; small molecule-based approaches.
Cancer Cell Int. 2021 Apr 13;21(1):208. doi: 10.1186/s12935-021-01924-w.
2
Immunohistochemical angiogenic biomarkers in hepatocellular carcinoma and cirrhosis: correlation with pathological features.
Clinics (Sao Paulo). 2016 Nov 1;71(11):639-643. doi: 10.6061/clinics/2016(11)04.
3
Effect of BZG-4000, a novel multi-targeted kinase inhibitor with potent anticancer activity, on a hepatocellular carcinoma xenograft model.
Sci Rep. 2014 Mar 17;4:4324. doi: 10.1038/srep04324.
4
The role of chemokines in acute and chronic hepatitis C infection.
Cell Mol Immunol. 2014 Jan;11(1):25-40. doi: 10.1038/cmi.2013.37. Epub 2013 Aug 19.
5
let-7b and miR-126 are down-regulated in tumor tissue and correlate with microvessel density and survival outcomes in non--small--cell lung cancer.
PLoS One. 2012;7(9):e45577. doi: 10.1371/journal.pone.0045577. Epub 2012 Sep 24.
6
Hypoxic and highly angiogenic non-tumor tissues surrounding hepatocellular carcinoma: the 'niche' of endothelial progenitor cells.
Int J Mol Sci. 2010 Aug 9;11(8):2901-9. doi: 10.3390/ijms11082901.
7
Mechanism of endothelial progenitor cell recruitment into neo-vessels in adjacent non-tumor tissues in hepatocellular carcinoma.
BMC Cancer. 2010 Aug 17;10:435. doi: 10.1186/1471-2407-10-435.
8
Particular distribution and expression pattern of endoglin (CD105) in the liver of patients with hepatocellular carcinoma.
BMC Cancer. 2007 Jul 4;7:122. doi: 10.1186/1471-2407-7-122.
9
Quantitative analysis using ELISA of vascular endothelial growth factor and basic fibroblast growth factor in human colorectal cancer, liver metastasis of colorectal cancer and hepatocellular carcinoma.
World J Gastroenterol. 2006 Jun 21;12(23):3782-3. doi: 10.3748/wjg.v12.i23.3782.
本文引用的文献
1
Platelet-activating factor and human thyroid cancer.
Eur J Endocrinol. 2005 Jul;153(1):31-40. doi: 10.1530/eje.1.01947.
2
Tumor cyclooxygenase-2 levels correlate with tumor invasiveness in human hepatocellular carcinoma.
World J Gastroenterol. 2005 Apr 7;11(13):1896-902. doi: 10.3748/wjg.v11.i13.1896.
3
Immunohistochemical assessment of angiogenesis in hepatocellular carcinoma and surrounding cirrhotic liver tissues.
World J Gastroenterol. 2005 Feb 21;11(7):960-3. doi: 10.3748/wjg.v11.i7.960.
4
Platelet-activating factor and liver metastasis of colorectal cancer.
Int J Cancer. 2005 Jan 20;113(3):503-5. doi: 10.1002/ijc.20585.
5
Quantitative analysis of basic fibroblast growth factor and vascular endothelial growth factor in human colorectal cancer.
Br J Cancer. 1998 Sep;78(6):765-70. doi: 10.1038/bjc.1998.575.
6
Vascular endothelial growth factor-induced in vitro angiogenesis and plasminogen activator expression are dependent on endogenous basic fibroblast growth factor.
J Cell Sci. 1997 Sep;110 ( Pt 18):2293-302. doi: 10.1242/jcs.110.18.2293.
Zotero 插件